Hereditary Cancer Test
Color Genomics Inc.
Color’s Hereditary Cancer Test analyzes relevant genes for mutations that could increase your risk for breast, colorectal, melanoma, ovarian, pancreatic, prostate*, stomach, and uterine cancers.
Color’s BRCA Test analyzes the BRCA1 and BRCA2 genes for mutations that can increase your risk for hereditary breast, ovarian, and other cancers. Mutations in BRCA1 and BRCA2 genes are the most common cause of hereditary breast and ovarian cancer.
Risk for women
A BRCA1 mutation can increase a woman’s chance of breast cancer up to 81% and ovarian cancer up to 54% by age 80.
A BRCA2 mutation can increase a woman’s chance of breast cancer up to 74% and ovarian cancer up to 12% by age 70.
Mutations in the BRCA1 and BRCA2 can also increase a woman’s chances of melanoma and pancreatic cancer.
Risk for men
Mutations in the BRCA1 and BRCA2 gene can also increase a man’s chances of male breast, melanoma, pancreatic, and prostate cancer.
Also, men are just as likely to have BRCA1 and BRCA2 mutations as women, and they are just as likely to pass them onto their children.
Counsyl Reliant Cancer Screen
If you have a personal or family history of cancer, find out your chances of developing breast, ovarian, colon, and other cancers.
Some of the genes we inherit from our parents are meant to protect us from certain cancers. Occasionally, we’ll inherit an irregular version of one of these genes, called a mutation. The Reliant Cancer Screen can look for irregularities in up to 36 genes that could mean you’re more susceptible to developing one of these cancers at some point in your life.
Invitae Multi-Cancer Panel
Genetic testing for 80 genes that are associated with hereditary cancers across eight major organ systems: breast and gyn, gastrointestinal, endocrine, genitourinary, skin, brain/nervous system, sarcoma, and hematologic.